. 2015 Jun 1;17(3):181–190. doi: 10.1089/cell.2014.0110

Table 2.

Effect of Different Protein Supplements on Developmental Capacity of Porcine IVF Embryos (r=4)

Treatment	No. of IVF oocytes	No. (%) of cleaved embryos on day 2	No. of assigned embryos on day 4	No. (%)^ of blastocysts on day 6*	No. of total cells on day 7 (mean±SEM)^*
Control (4 mg/mL BSA)	1462	940 (64.3)	235	44 (18.7±2.2)^a	42.76±3.86^a
10% FBS			235	65 (27.7±3.2)^b	59.79±4.84^b
10% hAT-MSC-BM			235	91 (38.7±4.2)^c	77.95±6.03^c
10% hESC-BM			235	79 (33.6±4.3)^bc	69.90±5.56^bc

^{^*}

p<0.05 for a–c superscripts.

IVF, in vitro fertilized; SEM, standard error of the mean; BSA, bovine serum albumin; FBS, fetal bovine serum; hAT-MSC-BM, human adipose tissue–derived mesenchymal stem cell bioactive material; hESC-BM, human embryonic stem cell bioactive material.